Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Matthew Worley

    Address9500 Gilman Drive #0930
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Behavioral economic mechanisms of prescription opioid addiction in chronic pain
      NIH/NIDA K23DA039348Apr 1, 2016 - Mar 31, 2021
      Role: Principal Investigator
      Mediators of Outpatient Treatment for Comorbid Substance Use Disorder and Major D
      NIH/NIDA F31DA030861Jan 25, 2011 - Jan 24, 2013
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Nguyen-Louie TT, Brumback T, Worley M, Colrain IM, Matt GE, Squeglia LM, Tapert SF. Effects of sleep on substance use in adolescents: a longitudinal perspective. Addict Biol. 2017 May 26. PMID: 28547821.
        View in: PubMed
      2. Roche DJO, Worley M, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl). 2017 Jul; 234(13):1997-2007. PMID: 28357460.
        View in: PubMed
      3. Isgro M, Doran N, Heffner JL, Wong E, Dinh E, Tibbs J, Russell K, Bittner T, Wehrle C, Worley M, Anthenelli RM. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men. J Stud Alcohol Drugs. 2017 Mar; 78(2):232-240. PMID: 28317503.
        View in: PubMed
      4. Worley M, Heinzerling KG, Shoptaw S, Ling W. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction. 2017 Jul; 112(7):1202-1209. PMID: 28164407.
        View in: PubMed
      5. Anthenelli RM, Heffner JL, Wong E, Tibbs J, Russell K, Isgro M, Dinh E, Wehrle C, Worley M, Doran N. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men. Alcohol Clin Exp Res. 2017 Jan; 41(1):197-206. PMID: 28029173.
        View in: PubMed
      6. Brumback TY, Worley M, Nguyen-Louie TT, Squeglia LM, Jacobus J, Tapert SF. Neural predictors of alcohol use and psychopathology symptoms in adolescents. Dev Psychopathol. 2016 Nov; 28(4pt1):1209-1216. PMID: 27739397.
        View in: PubMed
      7. Luk JW, Worley M, Winiger E, Trim RS, Hopfer CJ, Hewitt JK, Brown SA, Wall TL. Risky driving and sexual behaviors as developmental outcomes of co-occurring substance use and antisocial behavior. Drug Alcohol Depend. 2016 Dec 01; 169:19-25. PMID: 27750183.
        View in: PubMed
      8. Worley M, Heinzerling KG, Roche DJ, Shoptaw S. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study. Drug Alcohol Depend. 2016 May 01; 162:245-50. PMID: 26993372.
        View in: PubMed
      9. Choi TK, Worley M, Trim RS, Howard D, Brown SA, Hopfer CJ, Hewitt JK, Wall TL. Effect of adolescent substance use and antisocial behavior on the development of early adulthood depression. Psychiatry Res. 2016 Apr 30; 238:143-149. PMID: 27086224.
        View in: PubMed
      10. Worley M, Heinzerling KG, Shoptaw S, Ling W. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Exp Clin Psychopharmacol. 2015 Dec; 23(6):428-35. PMID: 26302337; PMCID: PMC4658240 [Available on 12/01/16].
      11. Trim RS, Worley M, Wall TL, Hopfer CJ, Crowley TJ, Hewitt JK, Brown SA. Bivariate Trajectories of Substance Use and Antisocial Behavior: Associations with Emerging Adult Outcomes in a High-Risk Sample. Emerg Adulthood. 2015 Aug 01; 3(4):265-276. PMID: 26889401.
        View in: PubMed
      12. Worley M, Witkiewitz K, Brown SA, Kivlahan DR, Longabaugh R. Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study. Alcohol Clin Exp Res. 2015 Jan; 39(1):93-100. PMID: 25623409; PMCID: PMC4418469.
      13. Worley M, Shoptaw SJ, Bickel WK, Ling W. Using behavioral economics to predict opioid use during prescription opioid dependence treatment. Drug Alcohol Depend. 2015 Mar 01; 148:62-8. PMID: 25622776; PMCID: PMC4666717.
      14. Khoddam R, Worley M, Browne KC, Doran N, Brown SA. Family history density predicts long term substance use outcomes in an adolescent treatment sample. Drug Alcohol Depend. 2015 Feb 01; 147:235-42. PMID: 25533896; PMCID: PMC4297729.
      15. Worley M, Trim RS, Tate SR, Roesch SC, Myers MG, Brown SA. Self-efficacy and social networks after treatment for alcohol or drug dependence and major depression: disentangling person and time-level effects. Psychol Addict Behav. 2014 Dec; 28(4):1220-9. PMID: 25347018; PMCID: PMC4651972.
      16. Worley M, Tate SR, Granholm E, Brown SA. Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression. J Consult Clin Psychol. 2014 Jun; 82(3):418-28. PMID: 24588403; PMCID: PMC4651969.
      17. Swanson AN, Shoptaw S, Heinzerling KG, Wade AC, Worley M, McCracken J, Wilson SA, Asarnow J, London ED. Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles. Subst Use Misuse. 2013 Dec; 48(14):1553-62. PMID: 23822739.
        View in: PubMed
      18. Worley M, Tate SR, McQuaid JR, Granholm EL, Brown SA. 12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Subst Abus. 2013; 34(1):43-50. PMID: 23327503; PMCID: PMC3558836.
      19. Worley M, Tate SR, Brown SA. Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression. Addiction. 2012 Nov; 107(11):1974-83. PMID: 22578037; PMCID: PMC3466338.
      20. Worley M, Trim RS, Roesch SC, Mrnak-Meyer J, Tate SR, Brown SA. Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. J Subst Abuse Treat. 2012 Oct; 43(3):291-302. PMID: 22406052; PMCID: PMC3382030.
      21. Bekman NM, Goldman MS, Worley M, Anderson KG. Pre-adolescent alcohol expectancies: critical shifts and associated maturational processes. Exp Clin Psychopharmacol. 2011 Dec; 19(6):420-32. PMID: 21942260; PMCID: PMC3777425.
      22. Mrnak-Meyer J, Tate SR, Tripp JC, Worley M, Jajodia A, McQuaid JR. Predictors of suicide-related hospitalization among U.S. veterans receiving treatment for comorbid depression and substance dependence: who is the riskiest of the risky? Suicide Life Threat Behav. 2011 Oct; 41(5):532-42. PMID: 21815915; PMCID: PMC3821394.
      23. Doran N, Sanders PE, Bekman NM, Worley M, Monreal TK, McGee E, Cummins K, Brown SA. Mediating influences of negative affect and risk perception on the relationship between sensation seeking and adolescent cigarette smoking. Nicotine Tob Res. 2011 Jun; 13(6):457-65. PMID: 21436297; PMCID: PMC3103719.
      24. Worley M, Trim RS, Tate SR, Hall JE, Brown SA. Service utilization during and after outpatient treatment for comorbid substance use disorder and depression. J Subst Abuse Treat. 2010 Sep; 39(2):124-31. PMID: 20598832.
        View in: PubMed
      25. Worley M, Gallop R, Gibbons MB, Ring-Kurtz S, Present J, Weiss RD, Crits-Christoph P. Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome. Am J Addict. 2008 May-Jun; 17(3):209-17. PMID: 18463998; PMCID: PMC2794690.